Therapeutic RNA Strategies for Chronic Obstructive Pulmonary Disease

被引：50
|
作者：
Mei, Dan [1 ]
Tan, W. S. Daniel [1 ]
Tay, Yvonne [2 ,3 ]
Mukhopadhyay, Amartya [4 ]
Wong, W. S. Fred [1 ,5 ,6 ]
机构：
[1] Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117600, Singapore
[2] Natl Univ Singapore, Canc Sci Inst Singapore, Ctr Translat Med, Singapore 117599, Singapore
[3] Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore
[4] Natl Univ Hlth Syst, Univ Med Cluster, Resp & Crit Care Med, Singapore 119228, Singapore
[5] Natl Univ Singapore, Immunol Program, Life Sci Inst, Singapore 117456, Singapore
[6] Natl Univ Singapore, Singapore HUJ Alliance Res & Enterprise, Singapore 138602, Singapore
来源：
TRENDS IN PHARMACOLOGICAL SCIENCES | 2020年 / 41卷 / 07期
基金：
新加坡国家研究基金会;
关键词：
ANTISENSE OLIGONUCLEOTIDES; IN-VIVO; COPD; INFLAMMATION; DELIVERY; PATHOGENESIS; PROTECTS; VERSICAN; SMOKERS; ASTHMA;
D O I：
10.1016/j.tips.2020.04.007
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Chronic obstructive pulmonary disease (COPD) is characterized by airflow limitation with persistent respiratory symptoms. Current therapeutics for COPD are largely borrowed from the drug armamentarium for the treatment of asthma, which has different pathophysiological mechanisms from COPD. COPD has been linked to dysregulated expression of mRNAs and noncoding (nc)RNAs including miRNAs, PIWI-interacting (pi)RNAs, long noncoding (lnc)RNAs, and circular (circ)RNAs. This review highlights and discusses some recent advances towards development of RNA therapeutics for COPD.
引用
收藏
页码：475 / 486
页数：12
相关论文
共 50 条
  • [21] Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease
    Donnelly, Louise E.
    Barnes, Peter J.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2006, 27 (10) : 546 - 553
  • [22] Different therapeutic responses in chronic obstructive pulmonary disease subgroups
    Lee, J. S.
    Huh, J. W.
    Chae, E. J.
    Seo, J. B.
    Ra, S. W.
    Lee, J-H.
    Kim, E-K.
    Lee, Y. K.
    Kim, T-H.
    Kim, W. J.
    Lee, J. H.
    Lee, S-M.
    Lee, S.
    Lim, S. Y.
    Shin, T. R.
    Yoon, H. I.
    Sheen, S. S.
    Oh, Y-M.
    Lee, S-D.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2011, 15 (08) : 1104 - 1110
  • [23] Therapeutic approaches to chronic obstructive pulmonary disease: An emerging consensus
    Chapman, KR
    AMERICAN JOURNAL OF MEDICINE, 1996, 100 : S5 - S10
  • [24] Therapeutic effect of phycocyanin on chronic obstructive pulmonary disease in mice
    Li, Wenjun
    Li, Yuanyuan
    Wang, Qi
    Liu, Runze
    Lu, Jianing
    Lu, Wenju
    Qin, Song
    JOURNAL OF ADVANCED RESEARCH, 2024, 66 : 285 - 301
  • [25] Invasive therapeutic concepts for chronic obstructive pulmonary disease and emphysema
    Wilkens, H.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2007, 132 (10) : 504 - 507
  • [26] Evaluating revefenacin as a therapeutic option for chronic obstructive pulmonary disease
    Antoniu, Sabina Antonela
    Rajnoveanu, Ruxandra
    Ulmeanu, Ruxandra
    Mihaltan, Florin
    Grigore, Mihaela
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (09) : 997 - 1004
  • [27] Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease
    Maria Gabriella Matera
    Clive Page
    Paola Rogliani
    Luigino Calzetta
    Mario Cazzola
    Drugs, 2016, 76 : 1257 - 1270
  • [28] Treatment Strategies in Chronic Obstructive Pulmonary Disease: A Proposal for Standardisation
    Luis Lopez-Campos, Jose
    ARCHIVOS DE BRONCONEUMOLOGIA, 2010, 46 (12): : 617 - 620
  • [29] Personalising exacerbation prediction strategies in chronic obstructive pulmonary disease
    Paul R Ellis
    Alice M Turner
    World Journal of Respirology, 2020, (02) : 11 - 16
  • [30] Self-management strategies in chronic obstructive pulmonary disease
    Bourbeau, Jean
    Nault, Diane
    CLINICS IN CHEST MEDICINE, 2007, 28 (03) : 617 - +
12345